BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis

World Journal of Biological Psychiatry

Volumn 15, Issue 5, 2014, Pages 411-418

  Brunoni, André R ^a   Baeken, Chris ^b,c   Machado Vieira, Rodrigo ^a,c   Gattaz, Wagner F ^a,d   Vanderhasselt, Marie Anne ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain derived neurotrophic factor; Electroconvulsive therapy; Meta analysis; Mood disorders; Systematic review

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

BIPOLAR DEPRESSION; DEMOGRAPHY; DEPRESSION; DEPRESSIVE PSYCHOSIS; ELECTROCONVULSIVE THERAPY; ELECTRODE IMPLANT; GENERAL CONDITION IMPROVEMENT; HUMAN; MEDLINE; META ANALYSIS; MOOD DISORDER; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; PUBLISHING; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT RESPONSE; BLOOD; MOOD DISORDERS;

BRAIN-DERIVED NEUROTROPHIC FACTOR; ELECTROCONVULSIVE THERAPY; HUMANS; MOOD DISORDERS;

EID: 84904306918     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2014.892633     Document Type: Review

References (44)

1. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, et al. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci: Offi cial J Soc Neurosci 24:2667-2677
2. Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TM. 2003. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54:703-709
3. Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29:261-265
4. Berlim MT, Van Den Eynde F, Daskalakis ZJ. 2013. Effi cacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: A systematic review and meta-Analysis of randomized trials. Depress Anxiety 30:614-623
5. Berrouschot J, Rolle K, Kuhn HJ, Schneider D. 1997. Serum neuron-specifi c enolase levels do not increase after electroconvulsive therapy. J Neurol Sci 150:173-176
6. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, et al. 2006. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharm: J Eur College Neuropsychopharm 16:620-624
7. Bolwig TG. 2011. How does electroconvulsive therapy work?. Theories on its mechanism. Can J Psychiatry. Revue Can Psychiatrie 56:13-18
8. Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Prog Neurobiol 76:99-125
9. Brunoni AR, Lopes M, Fregni F. 2008. A systematic review and meta-Analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11:1169-1180
10. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc
11. Dwork AJ, Christensen JR, Larsen KB, Scalia J, Underwood MD, Arango V, et al. 2009. Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience 164:1557-1564
12. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-Analysis detected by a simple, graphical test. Br Med J 315:629-634
13. Esel E, Kose K, Hacimusalar Y, Ozsoy S, Kula M, Candan Z, Turan T. 2008. The effects of electroconvulsive therapy on GABAergic function in major depressive patients. J ECT 24:224-228
14. Fernandes B, Gama CS, MassuDa R, Torres M, Camargo D, Kunz M, et al. 2009. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients. Neurosci Lett 453:195-198
15. Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, et al. 2011. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res 45:995-1004
16. Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R. 2012. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 3:12
17. Giese M, Unternaehrer E, Brand S, Calabrese P, Holsboer-Trachsler E, Eckert A. 2013. The interplay of stress and sleep impacts BDNF level. PLoS One 8:e76050
18. Gronli O, Stensland GO, Wynn R, Olstad R. 2009. Neurotrophic factors in serum following ECT: A pilot study. World J Biol Psychiatry: Off J World Fed Soc Biol Psychiatry 10:295-301
19. Group UER. 2003. Effi cacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-Analysis. Lancet 361:799-808
20. Haghighi M, Salehi I, Erfani P, Jahangard L, Bajoghli H, Holsboer-Trachsler E, et al. 2013. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. J Psychiatr Res 47:908-915
21. Hedges LV, Olkin I. 1985. Statistical methods for meta-Analysis. Orlando, FL: Academic Press
22. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. (updated september 2009). [Internet]. The Cochrane Collaboration, 2008; 2009
23. Hu Y, Yu X, Yang F, Si T, Wang W, Tan Y, et al. 2010. The level of serum brain-derived neurotrophic factor is associated with the therapeutic effi cacy of modifi ed electroconvulsive therapy in Chinese patients with depression. J ECT 26:121-125
24. Karege F, Schwald M, Cisse M. 2002. Postnatal developmental profi le of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261-264
25. Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, et al. 2010. Bifrontal, bitemporal and right unilateral electrode placement in ECT: Randomised trial. Br J Psychiatry: J Mental Sci 196:226-234
26. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefi ts: A meta-Analysis of data submitted to the Food and Drug Administration. PLoS Med 5:e45
27. Krishnan V, Nestler EJ. 2010. Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 167:1305-1320
28. Kuipers SD, Trentani A, Den Boer JA, Ter Horst GJ. 2003. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 85:1312-1323
29. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 6:e1000100
30. Lin CH, Chen MC, Lee WK, Chen CC, Huang CH, Lane HY. 2013. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients. Neuropsychobiology 68:110-115
31. Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, et al. 2007. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61:142-144
32. Marano CM, Phatak P, Vemulapalli UR, Sasan A, Nalbandyan MR, Ramanujam S, et al. 2007. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression. J Clin Psychiatry 68:512-517
33. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. 2014. Serum BDNF concentrations as peripheral manifestations of depression: Evidence from a systematic review and meta-Analyses on 179 associations (N - 9484). Mol Psychiatry 19:791-800
34. Okamoto T, Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Inoue Y, et al. 2008. Effi cacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study. Progr Neuro-Psychopharm Biol Psychiatry 32:1185-1190
35. Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E, et al. 2010. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specifi c enolase and S-100b protein. Psychiatry Res 177:97-100
36. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. 1998. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553-1561
37. Piccinni A, Del Debbio A, MedDa P, Bianchi C, Roncaglia I, Veltri A, et al. 2009. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharm: J Eur College Neuropsychopharm 19:349-355
38. Schule C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, et al. 2006. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31:1019-1025
39. Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-Analyses and implications. Biol Psychiatry 64:527-532
40. Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, et al. 2013. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharm: J Eur College Neuropsychopharm 23:1199-1207
41. Swartz CM, Nelson AI. 2005. Rational electroconvulsive therapy electrode placement. Psychiatry 2:37-43
42. Thase ME, Rush AJ. 1997. When at fi rst you don " t succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry 58(Suppl 13):23-29
43. Wahlund B, von Rosen D. 2003. ECT of major depressed patients in relation to biological and clinical variables: A brief overview. Neuropsychopharm: Offi cial Publ Am College Neuropsychopharmacol 28(Suppl 1):S212-216
44. Zunhammer M, Langguth B, Landgrebe M, Frank E, Muller S, Burger J, et al. 2011. Modulation of human motor cortex excitability by valproate. Psychopharmacology 215:277-280.